News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,273 Results
Type
Article (40730)
Company Profile (256)
Press Release (660287)
Section
Business (205221)
Career Advice (2032)
Deals (35573)
Drug Delivery (95)
Drug Development (81521)
Employer Resources (172)
FDA (16256)
Job Trends (14968)
News (347070)
Policy (32863)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2587)
Accelerated approval (2)
Adcomms (21)
Allergies (81)
Alliances (49777)
ALS (81)
Alzheimer's disease (1357)
Antibody-drug conjugate (ADC) (110)
Approvals (16254)
Artificial intelligence (227)
Autoimmune disease (13)
Automation (14)
Bankruptcy (368)
Best Places to Work (11729)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (180)
Bladder cancer (57)
Brain cancer (24)
Breast cancer (248)
Cancer (1968)
Cardiovascular disease (149)
Career advice (1698)
Career pathing (29)
CAR-T (140)
Cell therapy (394)
Cervical cancer (17)
Clinical research (65947)
Collaboration (760)
Compensation (446)
Complete response letters (19)
COVID-19 (2706)
CRISPR (34)
C-suite (203)
Cystic fibrosis (98)
Data (1898)
Decentralized trials (2)
Denatured (16)
Depression (37)
Diabetes (244)
Diagnostics (6379)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (109)
Drug pricing (96)
Drug shortages (25)
Duchenne muscular dystrophy (84)
Earnings (86235)
Editorial (32)
Employer branding (21)
Employer resources (146)
Events (112453)
Executive appointments (631)
FDA (17345)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (687)
Gene editing (94)
Generative AI (18)
Gene therapy (270)
GLP-1 (690)
Government (4483)
Grass and pollen (4)
Guidances (48)
Healthcare (19020)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (102)
Indications (26)
Infectious disease (2838)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (84)
Interviews (318)
IPO (16516)
IRA (40)
Job creations (3664)
Job search strategy (1442)
Kidney cancer (9)
Labor market (34)
Layoffs (449)
Leadership (15)
Legal (7960)
Liver cancer (70)
Lung cancer (291)
Lymphoma (129)
Machine learning (2)
Management (58)
Manufacturing (266)
MASH (60)
Medical device (13396)
Medtech (13401)
Mergers & acquisitions (19514)
Metabolic disorders (628)
Multiple sclerosis (67)
NASH (16)
Neurodegenerative disease (76)
Neuropsychiatric disorders (24)
Neuroscience (1820)
NextGen: Class of 2025 (6571)
Non-profit (4551)
Northern California (2391)
Now hiring (37)
Obesity (340)
Opinion (210)
Ovarian cancer (71)
Pain (75)
Pancreatic cancer (77)
Parkinson's disease (130)
Partnered (18)
Patents (200)
Patient recruitment (93)
Peanut (47)
People (57497)
Pharmaceutical (64)
Pharmacy benefit managers (18)
Phase I (20548)
Phase II (29022)
Phase III (21665)
Pipeline (963)
Podcasts (45)
Policy (107)
Postmarket research (2576)
Preclinical (8707)
Press Release (65)
Prostate cancer (92)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (350)
Real estate (5948)
Recruiting (65)
Regulatory (22331)
Reports (46)
Research institute (2344)
Resumes & cover letters (352)
Rett syndrome (3)
RNA editing (2)
RSV (38)
Schizophrenia (64)
Series A (121)
Series B (77)
Service/supplier (13)
Sickle cell disease (49)
Southern California (2061)
Special edition (14)
Spinal muscular atrophy (149)
Sponsored (30)
Startups (3616)
State (2)
Stomach cancer (12)
Supply chain (59)
The Weekly (26)
United States (20922)
Vaccines (685)
Venture capitalists (38)
Webinars (12)
Weight loss (229)
Women's health (33)
Worklife (15)
Date
Today (129)
Last 7 days (566)
Last 30 days (2688)
Last 365 days (33674)
2025 (7662)
2024 (35404)
2023 (40255)
2022 (51404)
2021 (56008)
2020 (54591)
2019 (46915)
2018 (35359)
2017 (32315)
2016 (31768)
2015 (37803)
2014 (31593)
2013 (26642)
2012 (28859)
2011 (29529)
2010 (27636)
Location
Africa (747)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (38293)
Australia (6240)
California (5451)
Canada (1855)
China (469)
Colorado (244)
Connecticut (256)
Delaware (123)
Europe (81877)
Florida (811)
Georgia (190)
Idaho (57)
Illinois (491)
India (23)
Indiana (288)
Iowa (9)
Japan (138)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (837)
Massachusetts (4103)
Michigan (208)
Minnesota (368)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (26)
Nevada (56)
New Hampshire (62)
New Jersey (1549)
New Mexico (28)
New York (1565)
North Carolina (923)
North Dakota (7)
Northern California (2391)
Ohio (191)
Oklahoma (14)
Oregon (33)
Pennsylvania (1238)
Puerto Rico (9)
Rhode Island (26)
South America (1115)
South Carolina (18)
South Dakota (1)
Southern California (2061)
Tennessee (92)
Texas (813)
Utah (165)
Virginia (130)
Washington D.C. (57)
Washington State (508)
West Virginia (3)
Wisconsin (48)
701,273 Results for "emergent biosolutions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products
March 19, 2025
·
1 min read
Press Releases
Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
March 10, 2025
·
4 min read
Press Releases
Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08
March 21, 2025
·
1 min read
Press Releases
Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results
March 4, 2025
·
41 min read
Press Releases
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates
March 12, 2025
·
5 min read
Press Releases
Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
February 19, 2025
·
1 min read
BioCapital
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
Emergent BioSolutions Inc. announced that it has entered into a “Consent, Waiver and Seventh Amendment” to its existing credit facility.
April 30, 2024
·
2 min read
Business
Emergent BioSolutions Reports First Quarter 2024 Financial Results
Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the first quarter ended March 31, 2024.
May 1, 2024
·
31 min read
Deals
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million
Emergent BioSolutions Inc. announced that it has entered into a definitive agreement to sell its drug product facility in Baltimore-Camden to an affiliate of Bora Pharmaceuticals Co., Ltd., a leading international pharmaceutical services company, for a total value of approximately $30 million.
June 20, 2024
·
4 min read
BioCapital
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
Emergent BioSolutions Inc. announced that its 2024 Annual Meeting of Stockholders will be held in a virtual-only format via live audio webcast on Thursday, May 23, 2024 at 9:00 am eastern time.
May 10, 2024
·
1 min read
1 of 70,128
Next
